International Journal of Medical Toxicology and Forensic Medicine

[1] Citaristi I. United Nations Office on Drugs and Crime—UNODC. in the Europa Directory of International Organizations 2022 2022 Jul 28 (pp. 248-52). Routledge. [DOI: 10.4324/9781003292548]

[2] Huang P, Chen MM. Systemic complications of illicit drug use: Pathophysiology and management. J Clin Med. 2021;10(2):201. [DOI: 10.3390/jcm10020201]

[3] Sarollahi R, Ghaderi A, Banafshe HR, Atlasi MA. Lifetime, last month and excessive prevalence of addictive substances consumption among the general population and university students in the city of Tehran. International Journal of High Risk Behaviors & Addiction. 2025;14(3). [DOI: 10.5812/ijhrba-159843]

[4] Zarei F, Simani M, Moghaddam HR, Ghaderi A. A review of cardiovascular diseases in substance use disorders: current knowledge and future perspectives. Addiction & Health. 2025;17:1722. [DOI: 10.34172/ahj.1722]

[5] Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatologic Clinics. 2011 Jan 1;29(1):111-23. [DOI: 10.1016/j.det.2010.08.010]

[6] Kim SJ, Park J, Lee JY, et al. Cutaneous signs and mechanisms of crack cocaine use: A scoping review. J Eur Acad Dermatol Venereol. 2019;33(4):637-43. [DOI: 10.1111/jdv.15420]

[7] Garcia JB, Cardoso MG, Dos-Santos MC. Opioids and the immune system: clinical relevance. Revista brasileira de anestesiologia. 2012;62:713-8. [DOI: 10.1016/S0034-7094(12)70171-6]

[8] Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D, Shover C. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug and alcohol dependence. 2022;233:109380. [DOI: 10.1016/j.drugalcdep.2022.109380]

[9] Waller JM, Feramisco JD, Alberta-Wszolek L, et al. Cocaine-associated retiform purpura and neutropenia: Is levamisole the culprit? J Am Acad Dermatol. 2010;63(3):530-5. [DOI: 10.1016/j.jaad.2009.07.005]

[10] Engels D. Cocaine use and levamisole-induced vasculitis: a multiple case study. Journal of Wound Ostomy & Continence Nursing. 2020;47(2):182-9. [DOI: 10.1097/WON.0000000000000628]

[11] Abd-Elsayed A, Troka M, Kim J, Moghim R, Kaye AD, Reilly M. The Connections Between Pain and Itch: Shared Neuroimmune Mechanisms and Therapeutic Implications. Current Pain and Headache Reports. 2026;30(1):49. [DOI: 10.2353/ajpath.2010.090457]

[12] Martin JL, Koodie L, Krishnan AG, Charboneau R, Barke RA, Roy S. Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. The American journal of pathology. 2010;176(2):786-99. [DOI: 10.2353/ajpath.2010.090445]

[13] Ho EL, Josephson SA, Lee HS, Smith WS. Cerebrovascular complications of methamphetamine abuse. Neurocritical care. 2009 Jun;10(3):295-305. [DOI: 10.1007/s12028-008-9177-5]

[14] Polvat T, Prasertporn T, Na Nakorn P, Pannengpetch S, Suwanjang W, Panmanee J, et al. Proteomic analysis reveals the neurotoxic effects of chronic methamphetamine self-administration-induced cognitive impairments and the role of melatonin-enhanced restorative process during methamphetamine withdrawal. Journal of proteome research. 2023;22(10):3348-59. [DOI: 10.1021/acs.jproteome.3c00395]

[15] Murugan K, Sivakumar A. Signs and terminologies in cutaneous manifestations of substance abuse. Indian Journal of Dermatology, Venereology and Leprology. 2024;90(5):682-6. [DOI: 10.1007/978-3-319-27580-2_8]

[16] Brezing C, Marcovitz D. Stigma and persons with substance use disorders. InStigma and prejudice: Touchstones in understanding diversity in healthcare 2016 (pp. 113-132). Cham: Springer International Publishing. [Link]

[17] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372. [DOI: 10.1136/bmj.n71]

[18] Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.

[19] Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infectious Disease Clinics. 2002;16(3):697-712. [DOI: 10.1016/s0891-5520(02)00017-x]

[20] Sadeghi M, Zakariaei Z, Yaghoubinia A, Abbasi A, Ashrafi M. Fatal peritonitis due to gastric perforation in a male heroin addict: a case report and literature review. International Journal of Surgery Case Reports. 2024;114:109116. [DOI: 10.1016/j.ijscr.2023.109116]

[21] Del Giudice P. Cutaneous complications of intravenous drug abuse. British Journal of Dermatology. 2004;150(1):1-0. [DOI: 10.1111/j.1365-2133.2004.05607.x]

[22] Benson JL, Campbell HE, Phillips CN. Opioid-induced pruritus. The Consultant Pharmacist®. 2015;30(4):221-7. [DOI: 10.4140/TCP.n.2015.221]

[23] Ali ZA, Sanders B, El-Mallakh R, Mathews M, Brown S. Treatment of Amphetamine-Induced Truman Show Delusion and Delusional Parasitosis with High-Dose Ziprasidone. Harvard Review of Psychiatry. 2023;31(4):202-7. [DOI: 10.1097/HRP.0000000000000369]

[24] Trimarchi M, Gregorini G, Facchetti F, Morassi ML, Manfredini C, Maroldi R, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine. 2001;80(6):391-404. [DOI: 10.1097/00005792-200111000-00005]

[25] Shrivastava S, Shrivastava S, Shrestha M, Mahaju S. Cannabis and Dermatological Implications: A Traditional Review of Adverse Cutaneous Reactions and Systemic Risks. Cureus. 2025;17(4). [DOI: 10.1136/bcr-2020-241456]

[26] Paillet-Loilier M, Cesbron A, Le Boisselier R, Bourgine J, Debruyne D. Emerging drugs of abuse: current perspectives on substituted cathinones. Substance abuse and rehabilitation. 2014:37-52. [DOI: 10.2147/SAR.S37257]

[27] Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emergency medicine journal. 2011;28(4):280-2. [DOI: 10.1016/j.jaad.2020.07.036]

[28] Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Digestive and Liver Disease. 2014;46:S165-73. [DOI: 10.1016/j.dld.2014.10.005]

[29] Heathcote J, Taylor KB. Immunity and nutrition in heroin addicts. Drug and alcohol dependence. 1981;8(3):245-55. [DOI: 10.1016/0376-8716(81)90068-5]

[30] Valencia J, Troya J, Lazarus JV, Cuevas G, Alvaro-Meca A, Torres J, et al. Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain. Open Forum Infect Dis. 2021 May 25;8(7):ofab251. [DOI: 10.1093/ofid/ofab251]

[31] Ramakrishnan K, Salinas RC, Higuita NI. Skin and soft tissue infections. American family physician. 2015;92(6):474-83. [Link]

[32] Behera A, Menakuru SR, Jindal R. Vascular complications of drug abuse: an Indian experience. ANZ Journal of Surgery. 2003;73(12):1004-7. [DOI: 10.1046/j.1445-2197.2003.t01-11-.x]

[33] Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clinical Infectious Diseases. 2001;33(1):35-40. [DOI: 10.1086/320879]

[34] Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, et al. Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: results from cross-sectional prevalence surveys, 1992-2013. JAIDS J Acquir Immune Defic Syndr. 2016;71(3):331-7. [DOI: 10.1097/QAI.0000000000000835]

[35] Dahlman D, Håkansson A, Kral AH, Wenger L, Ball EL, Novak SP. Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study. Substance abuse. 2017;38(1):105-12. [DOI: 10.1080/08897077.2016.1263592]

[36] Dunbar NM, Harruff RC. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. Journal of forensic sciences. 2007 Jul;52(4):920-3.Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(19):1945-54. [DOI: 10.1056/NEJMra042823]

[37] Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. Jama. 1998;279(11):859-63. [DOI: 10.1001/jama.279.11.859]

[38] Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infectious Disease Clinics. 2002;16(3):697-712. [DOI: 10.1016/s0891-5520(02)00017-x]

[39] Patnaik S, Balderia P, Vanchhawng L, Markazi P, Wykretowicz J, Perloff S. Is levamisole-induced vasculitis a relegated diagnostic possibility? A case report and review of literature. The American Journal of Case Reports. 2015;16:658. [DOI: 10.12659/AJCR.894477]

[40] Matar S, Dupin N, Petit AC, Gaillard R, Aractingi S, Oulès B. Cutaneous manifestations associated with substance use disorders. JAAD Reviews. 2025;4:206-1. [DOI: 10.1016/j.jaadrev.2025.01.001]

[41] Pieper B, Templin T, Ebright JR. Chronic venous insufficiency in HIV-positive persons with and without a history of injection drug use. Advances in skin & wound care. 2006;19(1):37-42. [Link]

[42] Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, Kuwana M, Fukuda Y. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med. 2010;49(5):361-9. [DOI: 10.2169/internalmedicine.49.2672]

[43] Ali ZA, Sanders B, El-Mallakh R, Mathews M, Brown S. Treatment of Amphetamine-Induced Truman Show Delusion and Delusional Parasitosis with High-Dose Ziprasidone. Harvard Review of Psychiatry. 2023;31(4):202-7. [DOI: 10.1097/HRP.0000000000000375]

[44] Avila C, Massick S, Kaffenberger BH, Kwatra SG, Bechtel M. Cannabinoids for the treatment of chronic pruritus: A review. Journal of the American Academy of Dermatology. 2020;82(5):1205-12. [DOI: 10.1016/j.jaad.2019.12.073]

[45] Sim MG, Khong E, Hulse G. Injecting drug use and skin lesions. Australian family physician. 2004;33(7). [Link]

[46] Chouk M, Vidon C, Deveza E, Verhoeven F, Pelletier F, Prati C, Wendling D. Puffy hand syndrome. Joint Bone Spine. 2017;84(1):83-5. [DOI: 10.1016/j.jbspin.2016.05.001]

[47] Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical infectious diseases. 2000;30(3):579-81.

[48] Cohen AL, Shuler C, McAllister S, Fosheim GE, Brown MG, Abercrombie D, Anderson K, McDougal LK, Drenzek C, Arnold K, Jernigan D. Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerging Infectious Diseases. 2007;13(11):1707. [DOI: 10.3201/eid1311.070148]

[49] Dartevel A, Chaigne B, Moachon L, Grenier F, Dupin N, Guillevin L, Bouillet L, Mouthon L. Levamisole-induced vasculopathy: a systematic review. InSeminars in Arthritis and Rheumatism 2019 Apr 1 (Vol. 48, No. 5, pp. 921-926). WB Saunders. [DOI: 10.1016/j.semarthrit.2018.07.010]

[50] Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, Arnold CL, Traylor JG, Orr AW. Methamphetamine use and cardiovascular disease: in search of answers. Arteriosclerosis, thrombosis, and vascular biology. 2019;39(9):1739-46. [DOI: 10.1161/ATVBAHA.119.312461]

[51] Tohda C, Nakanishi R, Kuraishi Y. Methamphetamine-induced dopaminergic neurotoxicity produces excessive grooming in mice. Behav Brain Res. 2009;203(2):267-72. [DOI: 10.1016/j.bbr.2009.05.015]

[52] Poonawala T, Levay‐Young BK, Hebbel RP, Gupta K. Opioids heal ischemic wounds in the rat. Wound Repair and Regeneration. 2005;13(2):165-74. [DOI: 10.1111/j.1067-1927.2005.130207.x]

[53] Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. British Journal of Dermatology. 2015;173(2):370-8. [DOI: 10.1111/bjd.13954]

[54] Zhang X, Liu Y, Wang J, et al. Cortical thinning in somatosensory regions correlates with formication severity in chronic methamphetamine users. Neuropsychopharmacology. 2023;48(8):1205-13. [DOI: 10.1038/s41386-023-01567-9]

[55] Yeung HM, Worrilow WM. Treatment of Xylazine‐Associated Injection Skin Injuries. Case Reports in Dermatological Medicine. 2024;2024(1):8618440. [DOI: 10.1155/2024/8618440]

[56] Eren Yİ, Hocaoğlu Ç. Dermatological Symptoms in Alcohol and Substance Use Disorders: A Review With Current Literature. Current Addiction Research. 2026 Jan 1;9(2):8-19. [DOI: 10.31038/CAR.202592102]

[57] Minkin W, Cohen HJ. Dermatologic complications of heroin addiction: Report of a new complication. New England Journal of Medicine. 1967;277(9):473-5. [DOI: 10.1056/NEJM196708312770907]

[58] Moradi-Joo M, Ghiasvand H, Noroozi M, Armoon B, Noroozi A, Karimy M, Rostami A, Mirzaee MS, Hemmat M. Prevalence of skin and soft tissue infections and its related high-risk behaviors among people who inject drugs: a systematic review and meta-analysis. Journal of substance use. 2019;24(4):350-60. [DOI: 10.1080/14659891.2019.1572794]

[59] Marquez J, Aguirre L, Muñoz C, Echeverri A, Restrepo M, Pinto LF. Cocaine-levamisole-induced vasculitis/vasculopathy syndrome. Current rheumatology reports. 2017;19(6):36. [DOI: 10.1007/s11926-017-0653-9]

[60] Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Digestive and Liver Disease. 2014;46:S165-73. [DOI: 10.1016/j.dld.2014.10.005]

[61] Polvat, Tanthai, et al. "Proteomic analysis reveals the neurotoxic effects of chronic methamphetamine self-administration-induced cognitive impairments and the role of melatonin-enhanced restorative process during methamphetamine withdrawal." Journal of proteome research 22.10 (2023): 3348-59. [DOI: 10.1021/acs.jproteome.3c00502]

[62] Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. Jama. 1998;279(11):859-63. [DOI: 10.1001/jama.279.11.859]

[63] Marschall MA, Dolezal RF, Cohen M, Marschall SF. Chronic wounds and delusions of parasitosis in the drug abuser. Plastic and reconstructive surgery. 1991;88(2):328-30. [DOI: 10.1097/00006534-199108000-00027]

[64] Cohen AL, Shuler C, McAllister S, Fosheim GE, Brown MG, Abercrombie D, et al. Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerging Infectious Diseases. 2007;13(11):1707. [DOI: 10.3201/eid1311.070356]

[65] Islam SN, Hossain KJ, Ahmed A, Ahsan M. Nutritional status of drug addicts undergoing detoxification: prevalence of malnutrition and influence of illicit drugs and lifestyle. British Journal of Nutrition. 2002;88(5):507-13. [DOI: 10.1079/BJN2002702]

[66] Skypala IJ, Jeimy S, Brucker H, Nayak AP, Decuyper II, Bernstein JA, Connors L, Kanani A, Klimek L, Lo SC, Murphy KR. Cannabis‐related allergies: an international overview and consensus recommendations. Allergy. 2022;77(7):2038-52. [DOI: 10.1111/all.15245]

[67] Chen S, Zhou W, Lai M. Synthetic cathinones: epidemiology, toxicity, potential for abuse, and current public health perspective. Brain sciences. 2024;14(4):334. [DOI: 10.3390/brainsci14040334]

[68] Chen S, Zhou W, Lai M. Synthetic cathinones: epidemiology, toxicity, potential for abuse, and current public health perspective. Brain sciences. 2024;14(4):334. [DOI: 10.3390/brainsci14040334]

[69] Sanchez DP, Tookes H, Pastar I, Lev-Tov H. Wounds and skin and soft tissue infections in people who inject drugs and the utility of syringe service programs in their management. Advances in Wound Care. 2021;10(10):571-82. [DOI: 10.1089/wound.2020.1223]

[70] Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-co]ntrol study. Clinical Infectious Diseases. 2001;33(1):35-40. [DOI: 10.1086/320879]

[71] Brown PD, Ebright JR. Skin and soft tissue infections in injection drug users. Current Infectious Disease Reports. 2002;4(5):415-9. [DOI: 10.1007/s11908-002-0008-0]

[72] Gordon RJ, Lowy FD. Bacterial infections in drug users. New England Journal of Medicine. 2005;353(18):1945-54. [DOI: 10.1056/NEJMra042823]

[73] Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC public health. 2008;8(1):405. [DOI: 10.1186/1471-2458-8-405]

[74] Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. The American journal of drug and alcohol abuse. 2010;36(2):92-7. [DOI: 10.3109/00952991003592311]

[75] Gontijo B, Bittencourt FV, Lourenço LF. Skin manifestations of illicit drug use. Anais Brasileiros de Dermatologia. 2006;81:307-17. [DOI: 10.1590/S0365-05962006000400002]

[76] Pieper B, Templin T, Ebright JR. Chronic venous insufficiency in HIV-positive persons with and without a history of injection drug use. Advances in skin & wound care. 2006;19(1):37-42. [DOI: 10.1097/00129334-200601000-00013]

[77] Fekri M, Fazeli M, Rasooli A, Jamali N, Bashar R, Pourhossein B. The influence of dexamethasone on apoptotic genes expression changes in rabies virus-infected mouse brain tissue. Iranian Journal of Pharmaceutical Sciences. 2025;21(1):11-9. [DOI: 10.22037/ijps.v21i1.45713]

[78] Mahboub N, Ayoub E, Mounzer C, Baltagi TK, Papandreou D, de Vries N, et al. Metabolic syndrome as a risk factor among Lebanese patients with substance use disorder undergoing treatment for recovery through rehabilitation or opioid substitution treatment. Clinics and Practice. 2024;14(6):2661-80. [DOI: 10.3390/clinpract14060209]

[79] Pollini RA, Gallardo M, Hasan S, Minuto J, Lozada R, Vera A, et al. High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. International Journal of Infectious Diseases. 2010;14:e117-22.10. [DOI: 1016/j.ijid.2010.02.2238]

[80] Sivyer GW, Rosendahl C. Levamisole-induced vasculopathy: A report of 5 cases. Australas J Dermatol. 2018;59(3):217-20. [DOI: 10.1111/ajd.12778]

[81] Chua K, Ridley K. The epidemiology of amphetamine type stimulant-related admissions in Albany, Western Australia: changes 10 years on. Australas Psychiatry. 2025;33(6):909-15. [DOI: 10.1177/10398562251318305]

[82] Ghaderi A, NasehGhafoori P, Rasouli-Azad, Mojtaba Sehat M, Mehrzad F, Nekuei M, Aaseth J, et al. "Examining of thallium in cigarette smokers." Biological trace element research. 2018;182(2):224-30. [DOI: 10.1007/s12011-017-1107-y]

[83] Ghaderi A, Khoshakhlagh AH, Gruszecka-Kosowska A, Alemi F, Hazegh P, Aghaei Z, et al. Blood-lead level in humans and drug addiction: a comprehensive study in Iran." Environmental Science and Pollution Research. 2023;30(52):2071-112085. [DOI: 10.1007/s11356-023-30179-3]

[84] Molavi N, Ghaderi A, Banafshe HR. Examining metabolic profiles in opioid-dependent patient. International Journal of Medical Toxicology and Forensic Medicine. 2020;10(3):28681. [DOI: 10.32598/ijmtfm.v10i3.28681]

[85] Simani M, Ghaderi A, Saffari I, Yazdani A, Rajabi Moghaddam H, Bagherian E. Evaluation of 10 Years Athero-sclerotic Cardiovascular Risk, Vitamin D and Metabolic Profiles in Smokers." International Journal of Medical Toxicology and Forensic Medicine. 2025;15(2):E47674. [DOI:10.32598/ijmtfm.v15i02.47674]